Evidence map›Paper›PMID 41835581›Full record

ArticleACS omega2026

IRIS: A Machine Learning-Based Pose Reranking Tool for RNA-Ligand Docking.

Jason Andrew Amburn, Shalini J Rukmani, Jerry M Parks, Jeremy C Smith

Abstract read
In one paragraph

Article in ACS omega, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jason Andrew AmburnBredesen Center for Interdisciplinary Research and Graduate Education, University of Tennessee, Knoxville, Tennessee 37996, United States.ORCID https://orcid.org/0000-0001-8752-3709
Shalini J RukmaniUT/ORNL Center for Molecular Biophysics, Oak Ridge National Laboratory, Oak Ridge, Tennessee 37831, United States.ORCID https://orcid.org/0000-0001-8474-9403
Jerry M ParksUT/ORNL Center for Molecular Biophysics, Oak Ridge National Laboratory, Oak Ridge, Tennessee 37831, United States.ORCID https://orcid.org/0000-0002-3103-9333
Jeremy C SmithUT/ORNL Center for Molecular Biophysics, Oak Ridge National Laboratory, Oak Ridge, Tennessee 37831, United States.ORCID https://orcid.org/0000-0002-2978-3227

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Given their fundamental roles in cellular processes and disease pathogenesis, RNA molecules are promising therapeutic targets. Predicting the 3D structure of RNA-ligand complexes using computational docking is a key element of rational, structure-based inhibitor design. However, RNA-ligand docking remains challenging, due in part to intrinsic properties of RNA such as structural flexibility and a highly charged phosphate backbone. rDock, a widely used RNA docking program, can generate ligand poses close to the experimental structure, but its scoring function frequently fails to rank these poses above less accurate alternatives. To supplement rDock, here we introduce the Intelligent RNA Interaction Scorer (IRIS), a regression model leveraging physicochemical and interaction-based features and trained on the largest data set of experimental nucleic acid-ligand complexes compiled to date for any ML-based tool designed for RNA docking (608 structures). IRIS improves rDock RNA-ligand pose ranking relative to the use of rDock scores alone. Using the best-performing rDock protocol on the RNA portion of the data set, we find that at least one of the 100 top generated poses for any given complex is within 2.0 Å RMSD of the native pose in 86.3% of test complexes. Of these 86.3%, the default rDock scoring function ranks the correct pose first in 42.7% of cases. IRIS improves this latter fraction to 59.8% and increases the success rate for selecting a near-native pose among the top five ranked poses from 64.6% to 78.0%. IRIS thus significantly enhances pose ranking accuracy and can be seamlessly integrated into docking pipelines to rerank ligand poses in RNA-targeted drug discovery.

Identifiers

PMID41835581
PMCPMC12980448

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.